|
|
| | Acetamide, 2-[(4-bromo-3-methylphenyl)amino]-N-ethyl- Basic information |
| | Acetamide, 2-[(4-bromo-3-methylphenyl)amino]-N-ethyl- Chemical Properties |
| Boiling point | 455.6±40.0 °C(predicted) | | density | 1.377±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 15.55±0.46(predicted) | | form | Solid | | color | Yellow to brown |
| | Acetamide, 2-[(4-bromo-3-methylphenyl)amino]-N-ethyl- Usage And Synthesis |
| Uses | JX237 is an inhibitor of the epithelial neutral amino acid transporter B0AT1 (SLC6A19) with an IC50 value of 31 nM. JX237 is the main transporter for the absorption of neutral amino acids in the intestines and their reabsorption in the kidneys. By inhibiting B0AT1, JX237 can help normalize elevated plasma amino acids in rare amino acid metabolic disorders like phenylketonuria and urea cycle disorders[1]. | | References | [1] Xu J, et al. Molecular basis of inhibition of the amino acid transporter B0AT1 (SLC6A19). Nat Commun. 2024 Aug 22;15(1):7224. DOI:10.1038/s41467-024-51748-1 |
| | Acetamide, 2-[(4-bromo-3-methylphenyl)amino]-N-ethyl- Preparation Products And Raw materials |
|